In this digital transformation race sprung about by COVID-19, companies like IMAPAC have rapidly increased the use of digital tools to stay afloat during the pandemic. Revamping from having a portfolio that consisted… read more

INFOGRAPHIC OF THE WEEK In a recent market outlook analysis by Genetic Engineering & Biotechnology News, the APAC global cell and gene therapy space has been predicted to emerge as a major market.… read more

IMAPAC recently rounded up its “Corona360 In-Conversation” series of live moderated interviews. It brought together vaccine industry experts in lively, thought-provoking discussions on the challenges and possible solutions in the race to develop… read more

Excerpt The International Vaccine Institute (IVI) will be conducting Phase 3 clinical trials of SK bioscience’s recombinant protein vaccine candidate (GBP510) in Europe and Southeast Asia, with the aim of bringing it to… read more

Excerpt The FDA has approved GSK’s Nucala (mepolizumab) as an add-on treatment in the US for adults with chronic rhinosinusitis with nasal polyps (CRSwNP). Mepolizumab is the first anti- interleukin-5 therapy to be… read more

Excerpt Results from an ongoing phase 2 clinical trial studying immunogenicity, safety, and immune persistence of CoronaVac ® show that while good immune memory is generated after the second dose, a third dose… read more

AGC Biologics announced multipurpose facility in its Copenhagen, Denmark site to increase its capacity and space to accommodate new and existing clients’ needs. The new facility will include a manufacturing building comprised of… read more

Lonza announced its plans to invest in establishing drug product manufacturing capabilities at its site in Guangzhou, China. The new investment will fund the installation of an aseptic drug product fill and finish… read more

Excerpt Vigil Neuroscience announces the completion of $90 million Series B financing led by Vida Ventures to advance its proprietary microglia-focused medicine line-up for the treatment of neurodegenerative diseases, adult-onset leukoencephalopathy with axonal… read more

Excerpt I-Mab announces positive interim results from its U.S. phase 2/3 study of plonmarlimab for the treatment of cytokine release syndrome (CRS) in patients with severe COVID-19. Data showed a higher rate of… read more

Excerpt Pfizer announces positive top-line results from the Phase 2b/3 ALLEGRO trial of once-daily ritlecitinib for the treatment of alopecia areata. Ritlecitinib 50 mg and 30 mg showed significantly a greater proportion of… read more

eTheRNA and Ghent University announce a collaboration and licence agreement for mRNA delivery facilitated by novel ionizable lipids co-developed with the university for a new generation of lipid nanoparticle (LNP) formulations, offering an… read more

Poseida Therapeutics and Cellares Corporation have formed a strategic relationship as part of Cellares’ Early Access Partnership Program (EAPP). Through the EAPP, Poseida will be able to access and help advance Cellares’ Cell… read more